Location History:
- Cambridgeshire, GB (2011 - 2012)
- Bedford, GB (2015)
- Cambridge, GB (2010 - 2017)
Company Filing History:
Years Active: 2010-2017
Title: **Benjamin P. Woolven: A Pioneer in Targeted Pulmonary Therapies**
Introduction
Benjamin P. Woolven is a distinguished inventor based in Cambridge, GB, recognized for his significant contributions to the field of therapeutic innovations. With a remarkable portfolio of 7 patents, Woolven has focused his research on addressing pulmonary diseases by developing advanced methods and agents that target specific tissues in the lungs.
Latest Patents
Woolven's latest patents demonstrate his commitment to improving medical treatments for respiratory conditions. One notable invention outlines methods for targeting pulmonary diseases with agents that bind to specific targets in pulmonary tissue. This patent describes the use of various agents, such as antibody fragments and ligands, formulated for local delivery to the pulmonary tissues. The formulation aims to provide long-acting therapeutic windows, thereby enhancing the treatment's efficacy. Additionally, it discloses the use of antagonists of Tumor Necrosis Factor Receptor 1 (TNFR1) for creating formulations or medicaments designed to treat or prevent lung inflammation and respiratory diseases. The patent also details the development of delivery devices, such as inhalers or intranasal devices, to facilitate these therapies.
Career Highlights
Throughout his career, Benjamin P. Woolven has held important roles in several reputable companies. He has worked with Domantis Limited and Cephalon Australia Pty. Ltd., where he contributed to advancing innovation in the pharmaceutical industry. His dedication to developing therapeutic solutions has positioned him as a key figure in pulmonology-focused research.
Collaborations
Woolven has collaborated with prominent professionals in the field, including Ian M. Tomlinson and Steve Holmes. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and the combining of expertise to enhance the effectiveness of their research efforts.
Conclusion
In conclusion, Benjamin P. Woolven stands out as an inventive force in the realm of pulmonary disease treatments. His extensive patent portfolio and collaborations with industry experts reflect his commitment to advancing medical technology. As he continues to explore innovative paths in therapeutics, Woolven’s contributions will likely play a crucial role in shaping the future of respiratory health.